S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
3 Words and a 3,000% Return (Ad)
Federal student loan payments are starting again. Here's what you need to know
Facing increasing pressure from customers, some miners are switching to renewable energy
3 Words and a 3,000% Return (Ad)
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
Rishi Sunak needs to rally his flagging Conservatives. He hopes a dash of populism will do the trick
The Bio-Tech Stock That Needs Your Attention! (Ad)
Bank of Japan survey shows manufacturers optimistic about economy
Donald Trump says he will be in courtroom for New York trial scrutinizing his business practices
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
3 Words and a 3,000% Return (Ad)
Federal student loan payments are starting again. Here's what you need to know
Facing increasing pressure from customers, some miners are switching to renewable energy
3 Words and a 3,000% Return (Ad)
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
Rishi Sunak needs to rally his flagging Conservatives. He hopes a dash of populism will do the trick
The Bio-Tech Stock That Needs Your Attention! (Ad)
Bank of Japan survey shows manufacturers optimistic about economy
Donald Trump says he will be in courtroom for New York trial scrutinizing his business practices
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
3 Words and a 3,000% Return (Ad)
Federal student loan payments are starting again. Here's what you need to know
Facing increasing pressure from customers, some miners are switching to renewable energy
3 Words and a 3,000% Return (Ad)
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
Rishi Sunak needs to rally his flagging Conservatives. He hopes a dash of populism will do the trick
The Bio-Tech Stock That Needs Your Attention! (Ad)
Bank of Japan survey shows manufacturers optimistic about economy
Donald Trump says he will be in courtroom for New York trial scrutinizing his business practices
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
3 Words and a 3,000% Return (Ad)
Federal student loan payments are starting again. Here's what you need to know
Facing increasing pressure from customers, some miners are switching to renewable energy
3 Words and a 3,000% Return (Ad)
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
Rishi Sunak needs to rally his flagging Conservatives. He hopes a dash of populism will do the trick
The Bio-Tech Stock That Needs Your Attention! (Ad)
Bank of Japan survey shows manufacturers optimistic about economy
Donald Trump says he will be in courtroom for New York trial scrutinizing his business practices
Followed 132 TimesTop Followed
NYSE:ABBV

AbbVie (ABBV) SEC Filings & 10K Form

$149.06
-3.19 (-2.10%)
(As of 09/29/2023 ET)
Compare
Today's Range
$148.83
▼
$152.53
50-Day Range
$141.63
▼
$154.70
52-Week Range
$130.96
▼
$168.11
Volume
5.58 million shs
Average Volume
3.97 million shs
Market Capitalization
$263.10 billion
P/E Ratio
30.67
Dividend Yield
3.97%
Price Target
$166.53
ProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability

Recent AbbVie SEC Filings

Export to Excel
DateFilerForm TypeView
09/27/2023
4:00 PM		AbbVie (Issuer)
GONZALEZ RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2023
4:00 PM		AbbVie (Issuer)
Alpern Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2023
3:01 PM		AbbVie (Subject)
GONZALEZ RICHARD A (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/31/2023
3:04 PM		AbbVie (Subject)
GONZALEZ RICHARD A (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/27/2023
6:45 AM		AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2023
4:04 PM		AbbVie (Issuer)
Donoghoe Nicholas (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/06/2023
3:18 PM		AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/29/2023
4:00 PM		AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2023
4:00 PM		AbbVie (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
05/05/2023
11:54 AM		AbbVie (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/04/2023
7:08 AM		AbbVie (Subject)
ZEVIN ASSET MANAGEMENT LLC (Filed by)
Form PX14A6G
04/27/2023
4:00 PM		AbbVie (Issuer)
Sorg Elaine K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/27/2023
6:36 AM		AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2023
3:16 PM		AbbVie (Subject)
AbbVie (Subject)
Sorg Elaine K. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/20/2023
2:39 PM		AbbVie (Subject)
Chevedden John (Filed by)
Form PX14A6G
04/17/2023
4:42 PM		AbbVie (Subject)
Sorg Elaine K. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/11/2023
11:34 AM		AbbVie (Subject)
AS YOU SOW (Filed by)
Form PX14A6G
04/05/2023
3:33 PM		AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2023
3:37 PM		AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2023
2:52 PM		AbbVie (Filer)
Form DEFA14A
03/28/2023
2:52 PM		AbbVie (Filer)
Form DEFA14A
03/28/2023
10:57 AM		AbbVie (Subject)
Chevedden John (Filed by)
Form PX14A6G
03/21/2023
4:19 PM		AbbVie (Filer)
Form DEFA14A
03/21/2023
4:21 PM		AbbVie (Filer)
Form ARS
03/20/2023
4:00 PM		AbbVie (Filer)
Form DEF 14A
03/20/2023
4:02 PM		AbbVie (Filer)
Form DEFA14A
03/10/2023
4:06 PM		AbbVie (Issuer)
Buckbee Kevin K (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/02/2023
3:35 PM		AbbVie (Issuer)
Hudson Thomas J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2023
4:00 PM		AbbVie (Issuer)
Siatis Perry C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2023
4:59 PM		AbbVie (Issuer)
Michael Robert A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2023
5:00 PM		AbbVie (Issuer)
RICHMOND TIMOTHY J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2023
5:02 PM		AbbVie (Issuer)
Stewart Jeffrey Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2023
5:06 PM		AbbVie (Issuer)
GONZALEZ RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2023
5:07 PM		AbbVie (Issuer)
Hudson Thomas J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2023
5:08 PM		AbbVie (Issuer)
Durkin Brian L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2023
5:10 PM		AbbVie (Issuer)
Reents Scott T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2023
5:11 PM		AbbVie (Issuer)
Siatis Perry C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2023
5:12 PM		AbbVie (Issuer)
Sorg Elaine K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2023
5:13 PM		AbbVie (Issuer)
SALEKI-GERHARDT AZITA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2023
5:14 PM		AbbVie (Issuer)
Strom Carrie C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2023
5:16 PM		AbbVie (Issuer)
AUSTIN ROXANNE S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2023
11:54 AM		AbbVie (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
01/10/2023
7:15 AM		AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2023
3:15 PM		AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2023
4:05 PM		AbbVie (Issuer)
RAPP EDWARD J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2023
4:06 PM		AbbVie (Issuer)
Alpern Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2022
4:06 PM		AbbVie (Issuer)
RICHMOND TIMOTHY J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2022
8:01 AM		AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2022
4:45 PM		AbbVie (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/04/2022
12:07 PM		AbbVie (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/28/2022
6:48 AM		AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/27/2022
4:01 PM		AbbVie (Issuer)
Siatis Perry C (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/17/2022
8:05 AM		AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/14/2022
4:02 PM		AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2022
4:08 PM		AbbVie (Issuer)
RAPP EDWARD J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies:
SEC Filings Tools:
This page (NYSE:ABBV) was last updated on 10/1/2023 by MarketBeat.com Staff

My Account -